Vapogenix

Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects. We are focused on treating pain locally – at its source. Our products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. Our first product, which recently completed its first clinical trial, is a rapidly acting topical analgesic to alleviate pain associated with venipuncture, venous cannulation and minor dermatological procedures. Our next products will focus on treating wound pain and localized inflammatory pain.
Type
Private
HQ
Houston, US
Founded
2006
Vapogenix was founded in 2006 and is headquartered in Houston, US

Vapogenix Office Locations

Vapogenix has office in Houston
Houston, US

Vapogenix Metrics

Vapogenix Summary

Founding Date

2006

Total Funding

$21.4 M

Latest funding size

$8.2 M

Time since last funding

3 months

Investors

We estimate that Vapogenix's latest funding round in December 2016 was $8.2 M. In total, Vapogenix has raised $21.4 M

Market Position – drug development, healthtech, pharmacy, clinical research, Health

Vapogenix Company Life

You may also be interested in